Measure your brain health
with Lila, the memory app.
Lila™ is a science-backed, reliable, and user-friendly way to measure your brain health from the comfort of your own home.
With decades of experience supporting the cognitive assessment needs of clinical trial and healthcare teams, the neuroscientists at Cogstate developed Lila as a tool anyone can use to better understand their memory and identify cognitive concerns.
Why measure brain health?
Brain changes associated with Alzheimer’s disease can begin 20 years before some symptoms start, and catching these changes as early as possible can be vitally important.
Lila is designed to test episodic memory, which is a common approach used to assess signs of cognitive impairment typical of early Alzheimer’s disease. Lila does not provide a diagnosis, but with the data provided you gain better understanding to:
Set a personal benchmark for your brain health, and track your memory overtime.
Make lifestyle choices such as diet, exercise, and social interactions, that can help modify your risk for dementia.
Talk to your doctor with more objective information about your experience.
Enroll in clinical trials that can offer additional treatment options.
The Lila test
Lila uses a testing paradigm known as “list learning” to evaluate your ability to learn and to remember. Simply put, you learn a list of words and repeat what you can remember!
Lila is based on the widely used Cogstate International Shopping List Test (ISLT). The ISLT has been leveraged by leading research teams worldwide to answer important questions about cognition during hundreds of clinical trials.
Testing takes about 15 minutes…
- Lila reads aloud a 12-item grocery list and you say as many items as you can remember. You repeat that process three times with the same grocery list.
- The testing process includes a waiting period. During this time, it is recommended that you do not write down items or repeat them in your head. This helps achieve more accurate results.
- Test performance feedback is immediately received. As you continue to use Lila, you can see your performance over time.
The process is both simple, and backed by decades of cognitive science.
Why Cogstate developed Lila
Memory decline is one of the earliest signs of Alzheimer’s disease, but today, testing for memory impairment requires a face-to-face visit with a trained and experienced neuropsychologist. This approach can place a high burden on patients and reduce access to care.
Cogstate aims to build tools that allow anyone to take brain measurement into their own hands. Products like Lila, and others, are a core part of this mission.
Lila was developed as part of an award received from the Alzheimer’s Drug Discovery Foundation (ADDF), which is a partnership of funders including Bill Gates, Jeff Bezos, Mackenzie Scott, the Dolby family, Leonard Lauder, and the Charles and Helen Schwab Foundation, among others.
Lila is not yet available for public use. If you are interested in helping us pilot Lila in your community, submit your details and we will contact you if opportunities become available.
